Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis

M Ugur; Mustafa Uğur; S Senöz; S. Şenöz; O Gökmen; Oya Gökmen

doi:10.1016/0301-2115(96)02499-2

Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis

M Ugur, Mustafa Uğur, S Senöz, S. Şenöz, O Gökmen, Oya Gökmen

European journal of obstetrics, gynecology, and reproductive biology · 1996 · vol. 68(1-2) , pp. 155–158 · doi:10.1016/0301-2115(96)02499-2 · PMID:8886699 · W1999542161

article OA: closed CC0 ⤵ 3 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the effectiveness and safety of combining a long-acting GnRH agonist with low-dose danazol for treating advanced stage endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Danazol Endometriosis Triptorelin Pamoate Adult Bone Density Danazol Danazol Danazol Endometriosis Female Fertility Follicle Stimulating Hormone Follicle Stimulating Hormone Humans Luteinizing Hormone Luteinizing Hormone Triptorelin Pamoate Triptorelin Pamoate Triptorelin Pamoate

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
Comparison of different treatment methods of endometriomas by laparoscopy. via openalex
CO <sub>2</sub> Laser Laparoscopy in Peritoneal Endometriosis and in Ovarian Endometrial Cyst via openalex
Cytosol estrogen and progestin receptor concentrations and 17β‐hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue via openalex
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis via openalex
Endometriosis and adenomyosis via openalex
Endometriosis of the lower genital tract. via openalex
Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex
Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex
Histochemical demonstration of estrogen and progesterone binding in endometriotic tissue and in uterine endometrium: A comparative study. via openalex
Human Endometrium and Endometriotic Tissue Obtained Simultaneously via openalex
Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment. via openalex
Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage via openalex
Postmenopausal endometriosis via openalex
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial via openalex
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
Short‐term effects of danazol on endometrial histology via openalex
Studies on GnRH Agonist Suppression of Estrogen Production in Patients with Endometriosis. via openalex
The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
Ultrastructural comparison of endometriotic implants and eutopic endometrium via openalex
W6603060888 via openalex
W2009881284 via openalex
W2403465350 via openalex
W2408619637 via openalex
W2417044776 via openalex
W1618997004 via openalex
W2477008945 via openalex

Cited by (3)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:10:57.821266+00:00

License: CC0 · commercial use OK

[1] Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex

[2] Comparison of different treatment methods of endometriomas by laparoscopy. via openalex

[3] CO <sub>2</sub> Laser Laparoscopy in Peritoneal Endometriosis and in Ovarian Endometrial Cyst via openalex

[4] Cytosol estrogen and progestin receptor concentrations and 17β‐hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue via openalex

[5] Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex

[6] Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis via openalex

[7] Endometriosis and adenomyosis via openalex

[8] Endometriosis of the lower genital tract. via openalex

[9] Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex

[10] Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue via openalex

[11] Histochemical demonstration of estrogen and progesterone binding in endometriotic tissue and in uterine endometrium: A comparative study. via openalex

[12] Human Endometrium and Endometriotic Tissue Obtained Simultaneously via openalex

[13] Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment. via openalex

[14] Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage via openalex

[15] Postmenopausal endometriosis via openalex

[16] Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial via openalex

[17] Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex

[18] Short‐term effects of danazol on endometrial histology via openalex

[19] Studies on GnRH Agonist Suppression of Estrogen Production in Patients with Endometriosis. via openalex

[20] The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex

[21] The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex

[22] Ultrastructural comparison of endometriotic implants and eutopic endometrium via openalex

[23] W6603060888 via openalex

[24] W2009881284 via openalex

[25] W2403465350 via openalex

[26] W2408619637 via openalex

[27] W2417044776 via openalex

[28] W1618997004 via openalex

[29] W2477008945 via openalex